Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).
Nakamura K, Tahara M, Kiyota N, Hayashi R, Akimoto T, Fukuda H, Fujii M, Boku N. Nakamura K, et al. Among authors: tahara m. Jpn J Clin Oncol. 2009 Jul;39(7):460-3. doi: 10.1093/jjco/hyp040. Epub 2009 May 8. Jpn J Clin Oncol. 2009. PMID: 19429640 Clinical Trial.
Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
Kiyota N, Tahara M, Okano S, Kawashima M, Matsuura K, Onozawa Y, Nibu K, Hayashi R, Yoshimura K, Ohtsu A. Kiyota N, et al. Among authors: tahara m. Jpn J Clin Oncol. 2012 Oct;42(10):927-33. doi: 10.1093/jjco/hys128. Epub 2012 Aug 23. Jpn J Clin Oncol. 2012. PMID: 22923484 Clinical Trial.
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Peña C, Molnár I, Schlumberger MJ; DECISION investigators. Brose MS, et al. Lancet. 2014 Jul 26;384(9940):319-28. doi: 10.1016/S0140-6736(14)60421-9. Epub 2014 Apr 24. Lancet. 2014. PMID: 24768112 Free PMC article. Clinical Trial.
Randomized phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck: Japan Clinical Oncology Group Study (JCOG1008).
Kunieda F, Kiyota N, Tahara M, Kodaira T, Hayashi R, Ishikura S, Mizusawa J, Nakamura K, Fukuda H, Fujii M; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group. Kunieda F, et al. Among authors: tahara m. Jpn J Clin Oncol. 2014 Aug;44(8):770-4. doi: 10.1093/jjco/hyu067. Epub 2014 May 19. Jpn J Clin Oncol. 2014. PMID: 24842866 Clinical Trial.
679 results